Pdb39 - Empagliflozin for Patients in the Netherlands With Type 2 Diabetes Mellitus and Established Cardiovascular Disease: A Budget Impact Model

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Effect of Empagliflozin on Cardiac Function, Adiposity, and Diffuse Fibrosis in Patients With Type 2 Diabetes Mellitus

Scientific Reports
Multidisciplinary
2019English

Impact of Atherosclerotic Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With Type 2 Diabetes Mellitus in a Real-World Setting

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2020English

Cardiovascular Safety of Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Pdb71 - Assessing the Relative Cost-Effectiveness of Empagliflozin and Canagliflozin for the Treatment of Type 2 Diabetes Patients With Existing Cardiovascular Disease in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2016English

Empagliflozin Promises to Bridge the Gap Between Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, and Cardiovascular Disease

Przeglad Gastroenterologiczny
Gastroenterology
2018English

"Type 1 on Type 2" Diabetes Mellitus: Autoimmune Type 1 Diabetes Superimposed on Established Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2007English

Early Prediction of Nephropathy and Cardiovascular Diseases in Indian Patients With Type 2 Diabetes Mellitus

International Journal of Medical Science and Public Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy